Press release
Diabetes Drugs Market Fueled by Global Diabetes Burden & Rise in GLP-1 Agonists - 2025 Trends Report | Sanofi, Novo Nordisk, Eli Lilly and Company
Diabetes Drugs Market
The latest Diabetes Drugs Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/diabetes-drugs-market?ophp
Diabetes drugs are used to regulate blood sugar levels in individuals with type 1 or type 2 diabetes, including insulin, metformin, SGLT2 inhibitors, and GLP-1 receptor agonists. Market growth is driven by the global diabetes epidemic, innovation in dual-purpose drugs offering cardiovascular benefits, and increased adoption of injectable and oral therapies.
Diabetes Drugs Market Competitors Overview:
The major global players in the diabetes drugs market include Sanofi, Novo Nordisk, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Merck & Co., Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, AstraZeneca., Bristol Myers Squibb, and GSK plc among others.
Important Industry Updates of 2024 and 2025:
In April 2024, Sanofi India officially launched its new diabetes medication, Soliqua, following the approval from the Central Drugs Standard Control Organization (CDSCO) last year. This drug is specifically designed for adults with obesity and type 2 diabetes mellitus, aimed at improving glycemic control as an adjunct to diet and exercise for those who have not achieved adequate control with existing oral or injectable therapies.
Diabetes Drugs Market Segments Overview:
∎ By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP-4 Inhibitors, SGLT2 Inhibitors, Biguanides, Thiazolidinediones, Meglitinides, Alpha-glucosidase Inhibitors)
∎ By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
∎ By Route of Administration (Oral, Parenteral)
∎ By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/diabetes-drugs-market?ophp
Methodology and Scope:
This Diabetes Drugs Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Diabetes Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=diabetes-drugs-market?ophp
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➤ What are the global sales, production, import, and export trends in the Diabetes Drugs market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Diabetes Drugs market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Drugs Market Fueled by Global Diabetes Burden & Rise in GLP-1 Agonists - 2025 Trends Report | Sanofi, Novo Nordisk, Eli Lilly and Company here
News-ID: 4098873 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Farm Management Software Market to Reach US$ 4.452B by 2032 | Key …
Leander, Texas and Tokyo, Japan - Jan.13.2026
The Farm Management Software Market size reached US$ 4,112.34 million in 2024 is expected to reach US$ 14,840.00 million by 2032, growing at a CAGR of 17.40% during the forecast period 2025-2032.
Market growth is driven by increasing adoption of precision agriculture, rising need for data-driven decision-making, and growing pressure to improve farm productivity and profitability. Advancements in cloud-based platforms, integration of AI,…
Healthcare Cloud Computing Market to Reach USD 54.72 Billion by 2033 | CAGR 13.2 …
Healthcare Cloud Computing Market Size & Industry Outlook
The global healthcare cloud computing market reached US$ 18.16 Billion in 2024, up from US$ 16.20 Billion in 2023, and is projected to reach US$ 54.72 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033. The market is witnessing strong growth as hospitals, clinics, and life sciences companies increasingly migrate to cloud platforms to improve data accessibility, interoperability,…
Oxygen Therapy Market to Reach USD 10.06 Billion by 2033 | CAGR 8.9% | North Ame …
Oxygen Therapy Market Overview
The global oxygen therapy market reached US$ 4.69 billion in 2024 and is projected to grow to US$ 10.06 billion by 2033, expanding at a CAGR of 8.9% during the forecast period 2025-2033. The market plays a crucial role in the healthcare sector, providing life-sustaining treatment for patients with various respiratory and cardiovascular conditions. Oxygen therapy is primarily administered to increase oxygen saturation in the blood for…
United States Human Milk Oligosaccharides (HMO) Market to Reach USD 255.15 Milli …
Leander, Texas and Tokyo, Japan - Jan.13.2026
The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 850.5 million by 2030. The market is growing at a CAGR of 20.1% during the forecast period 2024-2031.
Market growth is driven by rising demand for infant nutrition that closely mimics human breast milk, increasing awareness of…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
